Inventiva IVA
$3.14 −$0.31 (-8.99%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $3.18 +1.26%
Open$3.44
Prev close$3.45
Day range$3.13 – $3.44
Volume3.02M
Market cap$750.78M
P/E (TTM)–
Dividend yield–
IVA Stock News
Headlines matching Inventiva or the IVA ticker, most recent first.
- UBS Maintains Inventiva(IVA.US) With Buy Rating, Maintains Target Price $12
- A Quick Look at Today's Ratings for Inventiva(IVA.US), With a Forecast Between $12 to $21
- A Quick Look at Today's Ratings for Inventiva(IVA.US), With a Forecast Between $10 to $21
- Stifel Maintains Inventiva(IVA.US) With Buy Rating, Maintains Target Price $15
- Piper Sandler Maintains Inventiva(IVA.US) With Buy Rating, Maintains Target Price $26
- Guggenheim Maintains Inventiva(IVA.US) With Buy Rating, Raises Target Price to $14 Positive
- Analysts Conflicted on These Healthcare Names: BrightSpring Health Services, Inc. (BTSG), Inventiva (IVA) and Moderna (MRNA)
- Truist Financial Maintains Inventiva(IVA.US) With Buy Rating, Announces Target Price $13
- Cantor Fitzgerald Initiates Inventiva(IVA.US) With Buy Rating
- Barclays Maintains Inventiva(IVA.US) With Buy Rating, Maintains Target Price $18
- Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Rhythm Pharmaceuticals (RYTM) and Belite Bio, Inc. ADR (BLTE)
- TD Cowen Maintains Inventiva(IVA.US) With Buy Rating, Maintains Target Price $10
- Guggenheim Maintains Inventiva(IVA.US) With Buy Rating, Maintains Target Price $11
- A Quick Look at Today's Ratings for Inventiva(IVA.US), With a Forecast Between $12 to $20
- A Quick Look at Today's Ratings for Inventiva(IVA.US), With a Forecast Between $11 to $15
No comments yet — be the first to weigh in on IVA.
Sign in to join the discussion.